These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32807183)

  • 1. An overview of the commercial determinants of health.
    Mialon M
    Global Health; 2020 Aug; 16(1):74. PubMed ID: 32807183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food industry political practices in Chile: "the economy has always been the main concern".
    Mialon M; Corvalan C; Cediel G; Scagliusi FB; Reyes M
    Global Health; 2020 Oct; 16(1):107. PubMed ID: 33109216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the commercial determinants of health: a systematic review.
    de Lacy-Vawdon C; Livingstone C
    BMC Public Health; 2020 Jun; 20(1):1022. PubMed ID: 32600398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-market strategy as a framework for exploring commercial involvement in health policy: A primer.
    Eastmure E; Cummins S; Sparks L
    Soc Sci Med; 2020 Oct; 262():113257. PubMed ID: 32771875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'As Long as It Comes off as a Cigarette Ad, Not a Civil Rights Message': Gender, Inequality and the Commercial Determinants of Health.
    Hill SE; Friel S
    Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33137876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review.
    Mialon M; Vandevijvere S; Carriedo-Lutzenkirchen A; Bero L; Gomes F; Petticrew M; McKee M; Stuckler D; Sacks G
    BMJ Open; 2020 Jul; 10(7):e034082. PubMed ID: 32690498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automobile, construction and entertainment business sector influences on sedentary lifestyles.
    Parra DC; de Sá TH; Monteiro CA; Freudenberg N
    Health Promot Int; 2018 Apr; 33(2):239-249. PubMed ID: 27561906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks.
    Maani N; Collin J; Friel S; Gilmore AB; McCambridge J; Robertson L; Petticrew MP
    Eur J Public Health; 2020 Aug; 30(4):660-664. PubMed ID: 31953933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Structure and Agency as Commercial Determinants of Health Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention".
    Lee K; Crosbie E
    Int J Health Policy Manag; 2020 Jul; 9(7):315-318. PubMed ID: 32613804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conceptualizing the commercial determinants of dietary behaviors associated with obesity: A systematic review using principles from critical interpretative synthesis.
    Chavez-Ugalde Y; Jago R; Toumpakari Z; Egan M; Cummins S; White M; Hulls P; De Vocht F
    Obes Sci Pract; 2021 Aug; 7(4):473-486. PubMed ID: 34401205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposal for systematic monitoring of the commercial determinants of health: a pilot study assessing the feasibility of monitoring lobbying and political donations in Australia.
    Lacy-Nichols J; Cullerton K
    Global Health; 2023 Jan; 19(1):2. PubMed ID: 36611039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the Corporate and Commercial Determinants of Health.
    McKee M; Stuckler D
    Am J Public Health; 2018 Sep; 108(9):1167-1170. PubMed ID: 30024808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards Critical Analysis of the Political Determinants of Health Comment on "How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and What This Means for NCD Prevention".
    Smith J
    Int J Health Policy Manag; 2020 Mar; 9(3):121-123. PubMed ID: 32202096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
    Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
    Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proposed approach to systematically identify and monitor the corporate political activity of the food industry with respect to public health using publicly available information.
    Mialon M; Swinburn B; Sacks G
    Obes Rev; 2015 Jul; 16(7):519-30. PubMed ID: 25988272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations.
    Lacy-Nichols J; Nandi S; Mialon M; McCambridge J; Lee K; Jones A; Gilmore AB; Galea S; de Lacy-Vawdon C; de Carvalho CMP; Baum F; Moodie R
    Lancet; 2023 Apr; 401(10383):1214-1228. PubMed ID: 36966783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corporate practices and health: a framework and mechanisms.
    Madureira Lima J; Galea S
    Global Health; 2018 Feb; 14(1):21. PubMed ID: 29448968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Politics, welfare regimes, and population health: controversies and evidence.
    Muntaner C; Borrell C; Ng E; Chung H; Espelt A; Rodriguez-Sanz M; Benach J; O'Campo P
    Sociol Health Illn; 2011 Sep; 33(6):946-64. PubMed ID: 21899562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "The architecture of the state was transformed in favour of the interests of companies": corporate political activity of the food industry in Colombia.
    Mialon M; Gaitan Charry DA; Cediel G; Crosbie E; Baeza Scagliusi F; Pérez Tamayo EM
    Global Health; 2020 Oct; 16(1):97. PubMed ID: 33046110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.